Rifai N - Search Results

1

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. Pradhan AD, et al. Among authors: rifai n. JAMA. 2001 Jul 18;286(3):327-34. doi: 10.1001/jama.286.3.327. JAMA. 2001. PMID: 11466099 Clinical Trial.

2

Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study.

Kardys I, Rifai N, Meilhac O, Michel JB, Martin-Ventura JL, Buring JE, Libby P, Ridker PM. Kardys I, et al. Among authors: rifai n. Clin Chem. 2008 Jan;54(1):139-46. doi: 10.1373/clinchem.2007.094961. Epub 2007 Nov 16. Clin Chem. 2008. PMID: 18024525

3

Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment.

Ledue TB, Rifai N. Ledue TB, et al. Among authors: rifai n. Clin Chem. 2003 Aug;49(8):1258-71. doi: 10.1373/49.8.1258. Clin Chem. 2003. PMID: 12881440 Review.

4

Clinical efficacy of an automated high-sensitivity C-reactive protein assay.

Rifai N, Tracy RP, Ridker PM. Rifai N, et al. Clin Chem. 1999 Dec;45(12):2136-41. Clin Chem. 1999. PMID: 10585345 Clinical Trial.

5

High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy.

Yu H, Rifai N. Yu H, et al. Among authors: rifai n. Clin Biochem. 2000 Nov;33(8):601-10. doi: 10.1016/s0009-9120(00)00186-7. Clin Biochem. 2000. PMID: 11166006

6

Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis.

Albert MA, Rifai N, Ridker PM. Albert MA, et al. Among authors: rifai n. Vasc Med. 2001;6(3):145-9. doi: 10.1177/1358836x0100600304. Vasc Med. 2001. PMID: 11789968

7

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

Albert MA, Danielson E, Rifai N, Ridker PM; PRINCE Investigators. Albert MA, et al. Among authors: rifai n. JAMA. 2001 Jul 4;286(1):64-70. doi: 10.1001/jama.286.1.64. JAMA. 2001. PMID: 11434828 Clinical Trial.

8

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Ridker PM, Hennekens CH, Buring JE, Rifai N. Ridker PM, et al. Among authors: rifai n. N Engl J Med. 2000 Mar 23;342(12):836-43. doi: 10.1056/NEJM200003233421202. N Engl J Med. 2000. PMID: 10733371

9

Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening.

Redberg RF, Rifai N, Gee L, Ridker PM. Redberg RF, et al. Among authors: rifai n. J Am Coll Cardiol. 2000 Jul;36(1):39-43. doi: 10.1016/s0735-1097(00)00680-x. J Am Coll Cardiol. 2000. PMID: 10898410

10

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM Jr; Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Ridker PM, et al. Among authors: rifai n. N Engl J Med. 2001 Jun 28;344(26):1959-65. doi: 10.1056/NEJM200106283442601. N Engl J Med. 2001. PMID: 11430324 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results